Interleukin-6 genetic polymorphism and Chinese major depression

被引:23
作者
Hong, CJ
Yu, YWY
Chen, TJ
Tsai, SJ
机构
[1] Vet Gen Hosp, Dept Psychiat, Taipei 11217, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Dept Psychiat, Taipei 112, Taiwan
[3] E DA Hosp, Dept Psychiat, Kaohsiung, Taiwan
[4] E DA Hosp, Yus Psychiat Clin, Kaohsiung, Taiwan
[5] I Shou Univ, Kaohsiung, Taiwan
关键词
interleukin-6; major depressive disorders; polymorphism;
D O I
10.1159/000089003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: It has been reported that serum concentrations of interleukin-6 (IL-6), a pro-inflammatory cytokine, were significantly higher in major depressive disorder (MDD). Objectives: The aim of the present study was to examine whether the IL-6 genetic variant confers susceptibility to MDD. Methods: We genotyped a functional polymorphism in the promoter region ( position - 634) of the IL-6 gene in a sample of 257 MDD patients and 105 normal controls. Results: No significant differences were demonstrated for the genotype or allele frequency of the IL-6 polymorphism when comparing the MDD and control groups. Conclusions: Our findings suggested that the investigated IL-6 polymorphism does not affect MDD susceptibility. We propose that other genetic variations of IL-6, relating either to MDD or to the clinical manifestations of MDD, may need further investigation. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:202 / 205
页数:4
相关论文
共 24 条
[1]   Blood levels of cytokines in elderly patients with major depressive disorder [J].
Brambilla, F ;
Maggioni, M .
ACTA PSYCHIATRICA SCANDINAVICA, 1998, 97 (04) :309-313
[2]   Cytokines and depression: fortuitous or causative association? [J].
Dantzer, R ;
Wollman, E ;
Vitkovic, L ;
Yirmiya, R .
MOLECULAR PSYCHIATRY, 1999, 4 (04) :328-332
[3]  
Dunn AJ, 1999, ADV EXP MED BIOL, V461, P117
[4]   The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis [J].
Fishman, D ;
Faulds, G ;
Jeffery, R ;
Mohamed-Ali, V ;
Yudkin, JS ;
Humphries, S ;
Woo, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1369-1376
[5]   Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission [J].
Frommberger, UH ;
Bauer, J ;
Haselbauer, P ;
Fraulin, A ;
Riemann, D ;
Berger, M .
EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 1997, 247 (04) :228-233
[6]   Plasma concentrations of interleukin-1β, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor α of depressed patients in Japan [J].
Kagaya, A ;
Kugaya, A ;
Takebayashi, M ;
Fukue-Saeki, M ;
Saeki, T ;
Yamawaki, S ;
Uchitomi, Y .
NEUROPSYCHOBIOLOGY, 2001, 43 (02) :59-62
[7]   Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in Type 2 diabetes [J].
Kitamura, A ;
Hasegawa, G ;
Obayashi, H ;
Kamiuchi, K ;
Ishii, M ;
Yano, M ;
Tanaka, T ;
Yamaguchi, M ;
Shigeta, H ;
Ogata, M ;
Nakamura, N ;
Yoshikawa, T .
DIABETIC MEDICINE, 2002, 19 (12) :1000-1005
[8]   Cerebrospinal cytokine levels in patients with acute depression [J].
Levine, J ;
Barak, Y ;
Chengappa, KNR ;
Rapoport, A ;
Rebey, M ;
Barak, V .
NEUROPSYCHOBIOLOGY, 1999, 40 (04) :171-176
[9]   The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection [J].
Licinio, J ;
Wong, ML .
MOLECULAR PSYCHIATRY, 1999, 4 (04) :317-327
[10]   RELATIONSHIPS BETWEEN INTERLEUKIN-6 ACTIVITY, ACUTE-PHASE PROTEINS, AND FUNCTION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN SEVERE DEPRESSION [J].
MAES, M ;
SCHARPE, S ;
MELTZER, HY ;
BOSMANS, E ;
SUY, E ;
CALABRESE, J ;
COSYNS, P .
PSYCHIATRY RESEARCH, 1993, 49 (01) :11-27